Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication
Journal of Nanobiotechnology · 06.10.2024 · 22 (1)
DOI: 10.1186/s12951-024-02835-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Nanobiotechnology, online erschienen am 06.10.2024. Verfasst von He Mengyuan und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Biomimetic Materials, Drug Carriers. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Program of Shanghai Academic Research Leader, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Inspired by the concept of "natural camouflage," biomimetic drug delivery systems have emerged to address the limitations of traditional synthetic nanocarriers, such as poor targeting, susceptibility to identification and clearance, inadequate biocompatibility, low permeability, and systemic toxicity. Biomimetic nanocarriers retain the proteins, nucleic acids, and other components of the parent cells. They not only facilitate drug delivery but also serve as communication media to inhibit tumor cells. This paper delves into the communication mechanisms between various cell-derived biomimetic nanocarriers, tumor cells, and the tumor microenvironment, as well as their applications in drug delivery. In addition, the additional communication capabilities conferred on the modified biomimetic nanocarriers, such as targeting and environmental responsiveness, are outlined. Finally, we propose future development directions for biomimetic nanocarriers, hoping to inspire researchers in their design efforts and ultimately achieve clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China.
- Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
- Department of Oncology, Shanghai Medical College Fudan University, Shanghai, 200032, China.
- Department of Pharmacy, Huadong Hospital, Fudan University, Shanghai, 200040, China. xiaoyan5156@163.com.
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China. liujiyong@fudan.edu.cn.
- Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. liujiyong@fudan.edu.cn.
Förderung
- Program of Shanghai Academic Research Leader
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Cooperation Program of the Xuhui District Medical College with Enterprises
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Mengyuan, H., Aixue, L., Yongwei, G., Qingqing, C., Huanhuan, C., Xiaoyan, L., & Jiyong, L. (2024). Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication. Journal of Nanobiotechnology, 22(1). https://doi.org/10.1186/s12951-024-02835-4
Vancouver
Mengyuan H, Aixue L, Yongwei G, Qingqing C, Huanhuan C, Xiaoyan L, et al. Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication. Journal of Nanobiotechnology. 2024;22(1). doi:10.1186/s12951-024-02835-4
BibTeX
@article{Mengyuan2024,
author = {Mengyuan, He and Aixue, Li and Yongwei, Gu and Qingqing, Chai and Huanhuan, Cai and Xiaoyan, Liu and Jiyong, Liu},
title = {Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication},
journal = {Journal of Nanobiotechnology},
year = {2024},
volume = {22},
number = {1},
doi = {10.1186/s12951-024-02835-4}
}
EUVIMED